|
IHV researchers, clinicians and epidemiologists have helped build AIDS education and prevention programs from the ground up. Developing nations are hardest hit by the HIV/AIDS epidemic but have the fewest resources to combat the disease, educate the public or prevent infection. Patients have long encountered a shortage of proven therapeutics as well as doctors. And, medical professionals lack training opportunities to effectively diagnose, treat and prevent the disease.
For additional information on IHV's programs in Africa visit:
The Institute of Human Virology is committed to helping address these hurdles:
| In Nigeria, IHV scientists and epidemiologists are training health care providers on how to prevent transfusion of contaminated blood; are educating women on the risks of sexual transmission; are studying HIV in high-risk populations; are helping to develop tools to improve detection and risk assessment; and are equipping clinicians with the best treatment strategies for HIV patient care and the prevention of mother-to-child transmission. |
|
 |
|
|
In Malawi, IHV clinicians provide technical assistance to African physicians.
Though up to 40 percent of Malawi residents are HIV-positive, the number of physicians averages just two per 9,000 patients.
|
|
 |
|
| IHV scientists are working toward the development of a pediatric AIDS vaccine to prevent mother-to-child transmission. As many as one in three children in some African communities are HIV-infected by their very first birthday, usually as the result of breastfeeding. |
|
 |
|
| Through the International Fogarty Training Program, the IHV trains HIV/AIDS professionals from Africa the skills they need to more effectively combat the epidemic at home. |
|
 |
|
|
In the U.S., a growing number of African researchers and clinicians attend IHV’s Annual International Meeting, where they are joined by more than 700 leading scientists from around the world who report on the latest in HIV/AIDS research and often present unpublished data.
|
|
